transdermal Articles
ProStrakan’s Sancuso out-licensed by Solasia in Asia
4 March 2010
Belgium’s UCB to maximize US focus and resources on core products, hiving off primary care to Sanofi and Teva
1 February 2010
Alvogen acquires R&D capabilities and enters into multi-product development deal with Par Pharmaceutical
23 October 2009
Robert Wessman and Alvogen Group combine to build a leading international generics company
29 July 2009
Teikoku USA acquires Travanti Pharma
1 June 2009
J&J 1st qtr hit by market drop; keeps guidance
15 April 2009
Zosano patch equivalent to Lilly's Forteo
8 April 2009
Altea in Lilly/Amylin deal for diabetes patch
7 April 2009
Shire recalls 39 lots of Daytrana due to design flaws
30 March 2009
ProStrakan's 2008 revenue up 23%
30 March 2009
AGI's CID drug shows benefit at higher dose
23 March 2009
Shire withdaws EU Daytrana MAA
23 March 2009
Teikoku to help Eisai develop donepezil skin patch
16 March 2009
Japan stock market week to Mar 9, 2009
16 March 2009
Endo set to return rights to painkiller skin patch
16 March 2009
MRI danger for Teva patch and others
16 March 2009
Leconotide's potential for non-opioid pain relief
9 February 2009
FDA asks UCB to solve Neupro formulation
12 January 2009
Zosano complete end-of-Ph II ZP-PTH meeting with FDA
15 December 2008
Bayer signs deal for ProStrakan's Tostrex
15 December 2008
BioSante gets NIH grant for inhaled interferon
24 November 2008
Vivus' 3rd-qtr profit drops 79% on R&D costs
17 November 2008
ProStrakan's Sancuso launched in USA
10 November 2008
ProStrakan partners with NewBridge for Sancuso
10 November 2008
US FDA approves Teva's fentanyl patch
27 October 2008
Japan stock market week to Oct 20, 2008
27 October 2008
Durect licenses Eldur patch to Alpharma
6 October 2008
EpiCept amends deal with Durect
22 September 2008
Zosano sees good results for PTH Patch
22 September 2008
AGI's loss deepens on flat revenue
22 September 2008
Syntropharma raises $2.4M in second round of investment
15 September 2008
Noven in global deal with P&G on HSDD patch
1 September 2008
Thomson releases Pharma Matters reports for 1st qtr
1 September 2008
KV to use Acrux' spray for six new products
1 September 2008
Vivus returns to profit on Evamist gain
1 September 2008
Noven gets final $25M Shire milestone
11 August 2008
Vyteris to pursue joint developments in pain mangement
11 August 2008
Ph III salmon calcitonin trial completes recruitment
11 August 2008
BioSante gains new FDA SPA for Libigel
4 August 2008
Japan stock market week to June 23, 2008
30 June 2008
Lilly pays $35M for TP's osteoperosis patch
23 June 2008
Axxonis submits MAA for Nenad
9 June 2008
Nuvo licenses pain product from Paladin
9 June 2008
FDA accepts NDA on Watson's OAB gel
9 June 2008
Watson presents data on Ph III urology products
2 June 2008
JapanBridge to market Sancuso in SE Asia
2 June 2008
UCB report is cagey about interim results
26 May 2008
Burdica launches L2M fundraising program
21 April 2008
UCB drops 12% on Neupro batches recall
31 March 2008
Stock Commentary - Europe - week to March 24, 2008
31 March 2008
Vivus posts $10M 4th-qtr 2007 profit
24 March 2008
UCB's 2007 net profit down 59% on M&A
10 March 2008
Watson swings to profit of $38.4M in 4th qtr
3 March 2008
J&J/Actavis recall US lots of fentanyl patches
25 February 2008
AGI begins dosing in Ph II CID trial
11 February 2008
FDA tightens warning on J&J's Ortho Evra patch
28 January 2008
ProStrakan's 2007 sales exceed expectations
21 January 2008
Japan stock market week to Nov 14
7 January 2008
Galvus gets positive opinion from CHMP
24 December 2007
KV reports record sales in 2nd-qtr fiscal 2008
10 December 2007
Ardana's BPH drug effective with just two annual doses
26 November 2007
Novartis' Exelon patch launched in the UK
29 October 2007
NovaQuest signs accord on ProStrakan's Sancuso
29 October 2007
Japan stock market week to Oct 22, 2007
29 October 2007
UCB's Neupro effective for motor impairment in PD
15 October 2007
Tokyo stocks to October 8, 2007
15 October 2007
Exelon gets EC OK for Alzheimer's disease
1 October 2007
Hewlett Packard out-licenses drug patch technology to Crospon
24 September 2007
ProStrakan's 1st-half revenues jump 28%
24 September 2007
IDEA licenses Diractin to Alpharma
17 September 2007
Shire orders limited recall of Daytrana patch
10 September 2007
Japan stock market week to August 13, 2007
20 August 2007
ProStrakan out-licenses Sancuso in S Korea
20 August 2007
Vivus' 2nd-qtr loss grows 16% on Qnexa costs
13 August 2007
FDA clears EvaMist for menopause symptoms
6 August 2007
UCB's 1st-half profits fall 39% on Schwarz buy
6 August 2007
Stock Commentary - New York week to July 23, 2007
30 July 2007
CHMP recommends approval Exelon patch
30 July 2007
Japan stock market week to July 9, 2007
26 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Neupro patch for PD patients in the USA
23 July 2007
ProStrakan submits Sancuso MAA
23 July 2007
Stock Commentary - Europe - week to July 9, 2007
16 July 2007
Novartis progresses NM100060 using NexMed's NexACT
16 July 2007
Bradley Pharma debuts Elestrin in USA
18 June 2007
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- US Supreme Court says patent settlement can "sometimes" be illegal
- Actavis and Kissei file law suits against Sandoz and Hetero over Rapaflo patent
